Board of Directors

Director

Aaron serves on the advisory board of Doventi Capital Fund II L.P. Aaron practices law as a solicitor at Farris, Vaughan, Wills & Murphy LLP in Kelowna. Aaron specializes in the areas of corporate and commercial law, real estate, bank lending, and wills and estates. Aaron holds an undergraduate degree in Science as well as a Law degree, both from the University of Victoria. He also currently sits on the Board of Directors of the Metro Up Financial Literacy Society and is a member of both the Canadian Bar Association and the Kelowna Bar Association.

Director

Derek is a partner at Spence Valuation Group, where he specializes in business valuation, mergers and acquisitions and financial litigation support. Prior to joining SVG, he worked for national firms in valuations, transaction advisory and audit roles, in London, Kelowna and Vancouver. Derek has extensive experience in the valuation of privately-held companies for purchase & sales transactions, shareholder disputes, corporate reorganizations and estate freezes. Derek is a Chartered Professional Accountant (CPA), a Chartered Business Valuator (CBV) and a Chartered Financial Analyst (CFA).

Chairman and CEO

Norton currently serves as the Founder and Executive Chairman of Doventi Capital. Norton has extensive experience at the senior management level of capital investments and has been involved in several large acquisitions, consolidations, and start-ups in Canada’s legal cannabis sector, both private and public. As an investor and advisor to numerous companies in Canada’s ACMPR sector, he has been responsible for deploying over C$35M into the legal cannabis sector and has been involved in another C$50M of public M&A ACMPR transactions. Norton was also an advisor to, and significant investor in, Invictus MD (IMH.V).

As an experienced corporate leader, he has facilitated in regulatory matters, corporate matters, raising capital privately and publicly, as well as strategic corporate development within the public markets.

Vice President

Michael formerly served as a Director of Invictus. He is also an advisor to Doventi Capital.  Michael holds degrees in Kinesiology and Geology from Simon Fraser University. As a venture capitalist, he has been involved since 2009 in the start-up and senior management of numerous public companies as well as performing the role of Consultant and Advisor. In his recent role as Director and Senior Executive of Invictus, Michael helped oversee the acquisition, management and growth of a diverse portfolio of cannabis-centric businesses owned by Invictus. These businesses include manufacturing hydroponic equipment, laboratory testing and services, cultivation, media, marketing and biopharmaceutical applications. Michael has been directly involved in raising more than C$65M of capital in the cannabis sector.

Director

Kam is a Co-Founder and Managing Partner of Core Capital Partners (formerly Hamza Thindal Capital Corp., “Core”). Kam also currently serves on the advisory board of Doventi Capital. Kam holds a Bachelor of Technology in Technology Management from the British Columbia Institute of Technology. Prior to forming Core, Kam spent five years as an independent capital markets advisor for several TSX-V listed companies. In 2014, Kam lead both the private funding and IPO financing for Canada’s fifth licensed cannabis producer, Thunderbird Pharma (currently known as Emerald Health Botanicals – EMH.V), simultaneously attracting capital investors while acquiring a control position.  Kam and his partners have funded and acquired both medicinal and recreational cannabis assets in Canada and the US.

For the past seven years Kam has sourced investments, negotiated financings and acquisitions in various sectors with a particular focus on biotech, health care, technology and special situations, including cannabis in both private and public companies.  Kam has funded several pre-clinical and clinical stage health care companies with an aggregate investment of over C$50M.